Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1981 3
1982 2
1983 3
1984 3
1985 3
1986 1
1987 1
1988 6
1989 2
1990 4
1991 3
1992 2
1993 4
1995 1
1996 4
1997 2
1998 1
1999 2
2000 3
2001 4
2002 1
2003 2
2004 8
2005 6
2006 3
2007 6
2008 5
2009 5
2010 9
2011 6
2012 12
2013 5
2014 9
2015 8
2016 7
2017 3
2018 3
2019 5
2020 1
2021 2
2022 2
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Editorial Comment.
Dickstein R. Dickstein R. Urol Pract. 2024 Jan;11(1):60. doi: 10.1097/UPJ.0000000000000489.01. Epub 2023 Nov 9. Urol Pract. 2024. PMID: 37943984 No abstract available.
Reply by Authors.
Tyson MD, Morris D, Palou J, Rodriguez O, Mir MC, Dickstein RJ, Guerrero-Ramos F, Scarpato KR, Hafron JM, Messing EM, Cutie CJ, Maffeo JC, Raybold B, Chau A, Stromberg KA, Keegan KA. Tyson MD, et al. Among authors: dickstein rj. J Urol. 2023 May;209(5):900. doi: 10.1097/JU.0000000000003195.02. Epub 2023 Apr 7. J Urol. 2023. PMID: 37026638 No abstract available.
Motor imagery in physical therapist practice.
Dickstein R, Deutsch JE. Dickstein R, et al. Phys Ther. 2007 Jul;87(7):942-53. doi: 10.2522/ptj.20060331. Epub 2007 May 1. Phys Ther. 2007. PMID: 17472948 Review.
Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease.
Rose KM, Murray KS, Labbate C, Woldu S, Linehan J, Jacob J, Kaimakliotis H, Dickstein R, Feldman A, Matin SF, Lotan Y, Humphreys MR, Sexton WJ. Rose KM, et al. Among authors: dickstein r. Eur Urol Focus. 2023 Sep;9(5):807-812. doi: 10.1016/j.euf.2023.03.016. Epub 2023 Apr 12. Eur Urol Focus. 2023. PMID: 37059620 Review.
Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.
Linehan J, Gottlieb J, Woldu SL, Labbate C, Rose K, Sexton W, Kaimakliotis H, Jacob J, Dickstein R, Nieder A, Bjurlin M, Humphreys M, Ghodoussipor S, Quek M, O'Donnell M, Eisner BH, Feldman AS, Matin SF, Lotan Y, Murray KS. Linehan J, et al. Among authors: dickstein r. Eur Urol Focus. 2023 Nov;9(6):1052-1058. doi: 10.1016/j.euf.2023.05.012. Epub 2023 May 30. Eur Urol Focus. 2023. PMID: 37263827
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
Lotan Y, Agarwal P, Black P, Dickstein R, Kamat AM, Lee B, Narayan VM, Porten S, Psutka SP, Smith AK, Svatek RS, Williams SB, Woldu S. Lotan Y, et al. Among authors: dickstein r. Urol Oncol. 2024 Aug;42(8):223-228. doi: 10.1016/j.urolonc.2024.01.019. Epub 2024 Feb 1. Urol Oncol. 2024. PMID: 38307803 Review.
160 results